Dr. Lal PathLabs acquires full ownership of Centrapath Labs Private Limited
1 report, 1 independent
Updated Oct 13
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
PathLabs Unifiers Private Limited, a subsidiary of Dr. Lal PathLabs Limited, acquired the remaining 30 percent equity stake in Centrapath Labs Private Limited (CPL) for a cash transaction at a price of ₹1,608.352 per share. This acquisition made CPL a wholly-owned subsidiary of PathLabs Unifiers Private Limited.
From equitybulls.com
Why it matters
The transaction supports Dr. Lal PathLabs' strategic goal of consolidating ownership across its regional diagnostic service subsidiaries to strengthen its national network. CPL operates within the healthcare and diagnostic services sector in India, reporting turnover of ₹20.5 crore in FY 2025-26.
From equitybulls.com
Who's involved
- CPLCentrapath Labs Private Limited (CPL), the acquired diagnostic services company based in Indore, Madhya Pradesh.
- IndiaIndia, the country where CPL operates within the healthcare and diagnostic services sector.
- Madhya PradeshMadhya Pradesh, the state in central India where Centrapath Labs Private Limited is based.
Keep exploring
The entities involved
-
CPL
multi-paradigm programming language
Nothing else this week.
-
Madhya Pradesh
state in central India